3D Mammography Is Coming to European Screening. The Workload Question Comes With It.

Vara received CE mark under EU MDR (Class IIb) for its tomosynthesis AI in June 2026.

Jun 10 • Vara

1

May 2026

Vara is now available on Sectra’s Amplifier Marketplace platform.

Scaling AI across a screening program is an infrastructure challenge. Here's what it means that Vara now integrates with the world's most trusted…

May 7 • Vara

April 2026

Vara is partnering with Quibim to bring proven mammography AI to Spanish screening programs.

Spain's breast cancer screening programs are facing real capacity and cost pressure. Our new partnership with Quibim is built to help them respond.

Apr 28 • Vara

Vara is partnering with Medical Horizons to bring evidence-based mammography AI to Italy's screening programs.

Italy just became the first European country to formally recommend AI in organized mammography screening. Here's what our partnership with Medical…

Apr 21 • Vara

1

Two of Germany's leading AI radiology companies are partnering to bring evidence-based mammography AI to providers across Europe.

Vara and deepc are partnering to make evidence-based mammography AI accessible to providers across Europe—and what that means in practice.

Apr 9 • Vara and Anja Richter

1

October 2025

Vara receives CE mark for independent second reading in mammography

Breast screening programmes across Europe are under pressure from three directions at once: radiologist shortages, aging populations, and expanded…

Oct 15, 2025

2

January 2025

PRAIM: What the largest prospective AI study in healthcare means for breast screening

For years, the case for AI in radiology rested on retrospective data and small, controlled settings.

Jan 7, 2025

2